Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF01948373 | DOI Listing |
J ISAKOS
October 2024
Department of Orthopaedic Surgery, Singapore General Hospital, 20 College Road, Academia Building Level 4, 169856, Singapore.
Toxins (Basel)
May 2024
Spinal Unit, Department of Physical and Rehabilitation Medicine, Raymond Poincaré Teaching Hospital, APHP Paris Saclay, 92380 Garches, France.
BMC Musculoskelet Disord
May 2024
Gelenkpunkt - Sports and Joint Surgery, Innsbruck, Austria.
Bone Joint Res
April 2024
Technological Innovation Division, Foundation for Applied Medical Research (FIMA), University of Navarra (UNAV) and IdiSNA, Pamplona, Spain.
J Cachexia Sarcopenia Muscle
June 2024
Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and Gerontology, Obu, Japan.
Background: Recent studies have indicated the importance of muscle quality in addition to muscle quantity in sarcopenia pathophysiology. Intramuscular adipose tissue (IMAT), which originates from mesenchymal progenitors (MPs) in adult skeletal muscle, is a key factor affecting muscle quality in older adults, suggesting that controlling IMAT formation is a promising therapeutic strategy for sarcopenia. However, the molecular mechanism underlying IMAT formation in older adults has not been clarified.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!